InvestorsHub Logo
Followers 5
Posts 1048
Boards Moderated 1
Alias Born 02/13/2005

Re: None

Monday, 04/21/2008 11:05:09 AM

Monday, April 21, 2008 11:05:09 AM

Post# of 1549
"We have scheduled a MEETING IN APRIL"

Dr Ryan said in the last report below (caps mine). "We are looking forward to this meeting" and so am I. A good PR comapny would share the results with us - or keep us posted on what is happening. Looking forward to it.


"During the 4th quarter we continued our testing program with our European validation partner and announced the results from two rounds of testing in early January. Among the results we received, under certain processing conditions, we achieved up to 2 points of API gravity improvement, ~10% viscosity improvement, and shifting of the distillation components from higher to lower boiling (more valuable) components. For example, under one set of conditions, the crude fraction boiling above 432C, was reduced by ~15%, while the crude fraction boiling below 432C was increased by ~8%. Changes like this in the distillation curve distribution can have positive impact on refining economics, depending on the desired product slate.

I want to stress two points regarding these test results. To begin with, the crude we tested had an insignificant Sulphur content by weight, so we did not see, nor did we expect to see, any meaningful sulphur reduction in this crude.

Second, a 2 degree improvement on a 16 degree API crude represents a 12.5% shift in API, which is not an inconsequential number to a refiner.

Finally, I should also point out that we were able during one of these runs to successfully operate our equipment, without interruption, and at flow rates as high as 110% of design capacity, for 19 continuous hours using a Sulphco Series II design probe.

As I will discuss in a moment, our latest ultrasonic probe design (Series III) incorporates a number of new features, which we believe will achieve greater reliability and performance than the earlier generation probes.

We have scheduled a MEETING IN APRIL to meet with our European validation partner to discuss

1) the results from all of the trials to date,

2) further data collection and testing using updated probes, and...

3) potential commercial opportunities and terms. We are looking forward to this meeting and the opportunity to continued progress with our validation partner"

Best,
Terry

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.